Clinical Trial

Enhancing Generalization of Virtual Reality Exposure for Public Speaking Anxiety

Study acronym: VREX2
Recruiting
View on ClinicalTrials.gov →
Summary
This randomized controlled trial examines whether imagery-based extinction memory updating following a standardized virtual reality (VR) exposure session improves the generalization of exposure effects to novel public speaking contexts. Individuals with elevated public speaking anxiety will complete a single-session VR speech exposure. Participants are randomized to (a) standard mental rehearsal of the exposure experience or (b) mental rehearsal plus guided imagery that updates the extinction memory with novel, non-exposed contexts. Generalization is assessed 7-14 days later using a multi-context behavioral approach test (BAT) in vivo and in VR.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-22.
Trial Details
NCT Number NCT07323498
Lead Sponsor Philipps University Marburg
Conditions Public Speaking Anxiety, Public Speaking Fear
Enrollment 48 participants
Start Date 2025-11-26
Primary Completion 2026-11 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-09